UPC Court of Appeal grants Sanofi extra time in first ruling
The Munich local division was wrong to side with Amgen over the drugmaker’s failure to upload annexes to its infringement suit on time, the appeal court ruled
Stay updated with breaking news from Hoffmann Eitle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Munich local division was wrong to side with Amgen over the drugmaker’s failure to upload annexes to its infringement suit on time, the appeal court ruled
Investegate announcements from NuCana plc, Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid
Ruling Has No Impact on NuCana's Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical
24.03.2023 - Ruling Has No Impact on NuCana’s Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) - NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical Board of Appeal (the “TBA”) of the ... Seite 1
/PRNewswire/ -- Hoffmann Eitle Patent- und Rechtsanwälte PartmbB ("Hoffmann Eitle"), one of Europe's leading IP law firms, today announced that it has selected...